nsc 338720 has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benvenuto, JA; Farquhar, D; Hittelman, WN; Newman, RA; Pandita, TK; Plunkett, W; Zwelling, LA | 1 |
| Hartman, NR; O'Reilly, S; Schmid, SM; Shih, TW; Strong, JM; Struck, RF; Tiwari, A; Waud, WR | 1 |
2 other study(ies) available for nsc 338720 and Leukemia P388
| Article | Year |
|---|---|
Biochemical pharmacology of penclomedine (NSC-338720).
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Chromatography, High Pressure Liquid; Dihydroorotate Oxidase; DNA; DNA Damage; Humans; Leukemia P388; Malondialdehyde; Picolines; Uridine | 1995 |
4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine.
Topics: Animals; Antineoplastic Agents; Biotransformation; Breast Neoplasms; Humans; Leukemia P388; Male; Mice; Mice, Nude; Microsomes, Liver; Neoplasm Transplantation; Picolines; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Transplantation, Heterologous | 1997 |